{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_abatacept",
          "name": "Abatacept"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_anakinra",
          "name": "Anakinra"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bosentan",
          "name": "Bosentan"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_daclizumab",
          "name": "Daclizumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_methotrexate",
          "name": "Methotrexate"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_nintedanib",
          "name": "Nintedanib"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_pirfenidone",
          "name": "Pirfenidone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_teriflunomide",
          "name": "Teriflunomide"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_pb",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease",
          "type": "Disease",
          "label": "Familial Pulmonary Fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target1",
          "type": "Target",
          "label": "CD80",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target2",
          "type": "Target",
          "label": "TNF-alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target3",
          "type": "Target",
          "label": "IL-1",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target4",
          "type": "Target",
          "label": "Cytotoxic T lymphocyte antigen 4 (CTLA-4)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target5",
          "type": "Target",
          "label": "Fibroblast Growth Factor Receptors (FGFRs)",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_target6",
          "type": "Target",
          "label": "PDGF Receptors",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_abatacept",
          "target": "n_target4",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "CTLA-4 modulation indicated for immune-related diseases"
        },
        {
          "source": "n_target4",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Involved in immune response pathways"
        },
        {
          "source": "n_pb",
          "target": "n_disease",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Pathway implicated in pulmonary fibrosis"
        },
        {
          "source": "drug_adalimumab",
          "target": "n_target2",
          "relation": "acts_on",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "TNF-alpha inhibition relevant to fibrosis"
        },
        {
          "source": "n_target2",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Link to fibrogenic processes"
        },
        {
          "source": "drug_anakinra",
          "target": "n_target3",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "IL-1 inhibition shown in fibrosis"
        },
        {
          "source": "n_target3",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Modulates inflammatory response"
        },
        {
          "source": "drug_bosentan",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "FGFR inhibition has fibrotic implications"
        },
        {
          "source": "drug_nintedanib",
          "target": "n_target6",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "PDGF receptor antagonism known for fibrosis"
        },
        {
          "source": "n_target6",
          "target": "n_pb",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "Involved in pulmonary fibrotic progression"
        },
        {
          "source": "drug_pirfenidone",
          "target": "n_target5",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "FGF inhibition linked to antifibrotic effects"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过抑制免疫相关靶点影响家庭性肺纤维化的形成",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物能有效抵达肺部并介入病理通路"
    ],
    "uncertainties": [
      "具体药物间交互作用的临床意义尚需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需要探讨其他药物的潜在抑制作用以及与此病症的关系？"
    ]
  }
}